Svmuu News: Crypto exchange Kraken's affiliated special purpose acquisition company (SPAC), KRAKacquisition Corp., announced it has initiated a search for potential merger and acquisition targets. The target company's valuation could reach up to $10 billion. It is reported that the SPAC is extensively evaluating crypto-native enterprises, including companies in related fields such as stablecoins, tokenization, DeFi, and payments. KRAKacquisition previously completed a $345 million IPO and was granted two years to find a merger target. It stated that the $10 billion figure is merely a rough upper valuation limit, and the target company's actual valuation is likely closer to $2 billion. However, this range reflects the company's desire to provide a pathway for small to mid-cap companies to enter the public market.
Meanwhile, Kraken itself is advancing its own listing plans. The exchange previously confidentially submitted registration documents to the U.S. Securities and Exchange Commission and completed a financing round of approximately $800 million last year, valuing the company at around $20 billion. KRAKacquisition is also seen as Kraken's strategic investment vehicle, aiming to form closer economic ties with acquired companies through equity holdings. (Decrypt)
Kraken-affiliated SPAC Seeks Potential M&A Targets, Target Company's Actual Valuation May Approach $2 Billion
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
3
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
4
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
5
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
6
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
7
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
8
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
9
Iran-linked exchange Shelbit allegedly sent $676 million to Binance in sanctions-evasion operation, Reuters reports
-
10
NVIDIA and AMD: The Two Giants of AI Computing Power in 2026—An Analysis of Market Dynamics, Financial Performance, and Opportunities for Transition into Cryptocurrency Mining
Markets Today
Recommended Reading









